The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 of 6 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Normal and diabetic group sizes are reversed for the CIGMA comparison
MinorThe methods say the CIGMA comparison used 12 normal subjects and 11 diabetic patients, but the results report 11 normal subjects and 12 diabetic subjects.
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 27,101–27,200 of 31,469
Es la acantosis nigricans un signo de insulinorresistencia en adolescentes obesos
Hirschler, V., Aranda, C., Oneto, A., González, C. D., Delfino, A. M., Clemente, G., Portanova, M., & Jadzinsky, M. N. (2004) · Archivos Argentinos de Pediatria · Cited by 2
Estimation and personalization of clinical insulin therapy parameters
Palma, R. C. (2013) · Texas ScholarWorks (Texas Digital Library) · Cited by 2
Serum Adiponectin levels in Different Phenotypes of Polycystic Ovary Syndrome
Otta, C. F., de Mereshian, P. S., Kaplan, R., Iraci, G. S., Ojeda, S., Ochoa, J., Albrecht, A., Filipone, N., & de Cúneo, M. F. (2012) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2012.24019 · Cited by 2
[Dietary patterns and physical activity in the mexican population: association with fatty liver].
González-Salazar, M. D. C., Medina-Urrutia, A. X., Juárez-Rojas, J. G., Cardoso-Saldaña, G. C., Posadas‐Sánchez, R., Martínez-Alvarado, M. R., Galarza, E. J., & Posadas‐Romero, C. (2014) · PubMed · Cited by 3
Kvitkova, L. V., Borodkinа, D. A., Gruzdeva, O. V., Силонова, А. А., Жаркова, О. Н., & Барбараш, О. Л. (2012) · Problems of Endocrinology · doi:10.14341/probl201258427-31 · Cited by 2
Adverse effects of obesity on β-cell function in Japanese subjects with normal glucose tolerance
Akehi, Y., Anzai, K., Katsuta, H., Yoshida, R., Ohkubo, K., Yamashita, T., Kawashima, H., & Ono, J. (2008) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2008.05.002 · Cited by 3
Insulin Resistance in Egyptian Nonalcoholic Fatty Liver Disease patients
Mohamed, A. A., Shousha, W. G., Shaker, O. G., Mahdy, M., Ibrahim, E., Aal, H. A. A., Hamid, A., Azzat, M., & Shimy, A. E. (2015) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2015/11380 · Cited by 2
Familial short fifth metacarpals and insulin resistance
Hyari, M., Hamamy, H., Barham, M., et al. (2005) · Skeletal Radiology · doi:10.1007/s00256-005-0939-2 · Cited by 2
Aires, L., Silva, G., Alves, A. I., Medeiros, A., Nascimento, H., Magalhães, C., Martins, C., Rocha‐Pereira, P., Santos‐Silva, A., Belo, L., et al. (2015) · Retos · doi:10.47197/retos.v0i28.34957 · Cited by 6
Metabolic and lipoprotein aspects of polycystic ovarian syndrome
Pazderska, A., & Gibney, J. (2015) · Clinical Lipidology · doi:10.2217/clp.15.12 · Cited by 2
Lixandru, D., Băcanu, E. V., Vîrgolici, B., Emil, M., Gagniuc, P. A., Ionescu-Tirgoviste, C., & Serafinceanu, C. (2015) · Cited by 2
Praveen, E. P., Chouhan, S. S., Sahoo, J., Goel, S. K., Dwivedi, S. N., Khurana, M. L., Kulshreshtha, B., & Ammini, A. C. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0379 · Cited by 2
Soori, R., Asad, M., Barahouei-Jamar, Z., et al. (2016) · KAUMS Journal · Cited by 2
Ghudhaib, K. K., Turki, K. M., Mezel, S. A., et al. (2014) · IOSR Journal of Applied Chemistry · doi:10.9790/5736-0752119122 · Cited by 2
Kartikawati, A., Lina, Y., & Wijaya, A. (2012) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v4i2.166 · Cited by 2
Dzurik, R., Krivošíková, Z., Stefikova, K., & Spustová, V. (2006) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03656870 · Cited by 2
Tifacogin (Chiron Corp/Pharmacia Corp).
Sne, N., Ondiveeran, H. K., & Fox‐Robichaud, A. (2002) · PubMed · Cited by 2
Usgaonkar, A. P., & Amonkar, C. Y. D. A. S. D. (2012) · International Journal of Pharma and Bio Sciences · Cited by 2
Hasaneen, B., Salem, N. A., Sallab, S. M. E., et al. (2016) · Egyptian Pediatric Association Gazette · doi:10.1016/j.epag.2016.09.003 · Cited by 2
García-Villegas, E. A., Márquez-González, H., Flores-Suárez, L. F., et al. (2016) · Medicina Clínica · doi:10.1016/j.medcli.2016.09.017 · Cited by 2
Effects of 12 Weeks of Yoga Training Program on Stress and Depression Index in Middle-Aged Women
Yoon, T. E., Jung, W., & Lee, M.-G. (2016) · Exercise Science · doi:10.15857/ksep.2016.25.4.265 · Cited by 2
García-Villegas, E. A., Márquez-González, H., Flores-Suárez, L. F., et al. (2017) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2016.09.034 · Cited by 2
González, E., Díez, J. J., Torres, A. P., Bajo, M. A., del Peso, G., Sánchez, R. J., Grande, C., Rodríguez, O., Coronado, M., Candela, C. G., et al. (2017) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2017.04.001 · Cited by 3
INFLAMMATORY MARKERS IN PRE-DIABETICS
Bose, S., Maity, C., & Roy, N. (2016) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2016/482 · Cited by 2
Insulin Resistance and Other Mechanisms of Obesity Hypertension
Thaker, V., & Falkner, B. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-31420-4_39-1 · Cited by 2
SERUM NESFATIN-1 LEVELS IN EXPERIMENTALLY-INDUCED POLYCYSTIC OVARY IN LEAN AND OBESE ALBINO RATS
Gerges, N., & Khalefa, A. A. (2016) · Al-Azhar Medical Journal · doi:10.12816/0034751 · Cited by 2
Association between Nitrogen Stable Isotope Ratios in Human Hair and Serum Levels of Leptin
Ahn, S. V., Koh, S. B., Lee, K., Bong, Y., & Park, J.-K. (2017) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.243.133 · Cited by 2
Correlation between PAI-1, leptin and ferritin with HOMA in HIV/AIDS patients
Dragović, G., Šumarac-Dumanović, M., Al-Musalhi, K., Soldatović, I., Andjić, M., Jevtović, D., & Nair, D. R. (2018) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2018.06.004 · Cited by 2
Stelmaszyk, A., Wesołowska, A., Pomieczyńska, K., et al. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2018.07.008 · Cited by 2
Yamori, Y., Sagara, M., Arai, Y., Kobayashi, H., Kishimoto, K., Matsuno, I., Mori, H., & Mori, M. (2018) · Journal of Nutrition in Gerontology and Geriatrics · doi:10.1080/21551197.2018.1496512 · Cited by 2
Tu, C., Hsu, C.-Y., Lee, M.-H., et al. (2018) · Laboratory Animal Research · doi:10.5625/lar.2018.34.4.185 · Cited by 2
Khoramjah, M., Khorshidi, D., & Karimi, M. (2017) · Salmand · doi:10.32598/sija.13.10.450 · Cited by 3
Abdelrazek, H. M. A., Zeidan, D. W., Eltamany, D. A., et al. (2017) · Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology/Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology · doi:10.21608/eajbsc.2017.26279 · Cited by 2
de Luis, D. A., Calvo, S. G., Primo, D., Izaola, O., & Pacheco, D. (2019) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2019.03.002 · Cited by 2
Quantification of Insulin Action in Human Subjects
Krentz, A. J., Weyer, C., & Hompesch, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-11748-1_1 · Cited by 3
Drummen, M., Heinecke, A., Dorenbos, E., Vreugdenhil, A. C. E., Raben, A., Westerterp‐Plantenga, M. S., & Adam, T. C. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.06.017 · Cited by 2
Rajendran, J., Srinivasan, A. R., & Maran, A. L. (2019) · Europe PMC (PubMed Central) · Cited by 2
Helal, E. G. E., Abdelaziz, M. A., Fadel, H. A. E., et al. (2019) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2019.34259 · Cited by 2
Optimized fasting and OGTT-based simple surrogate methods for assessing insulin sensitivity
Altuve, M., Severeyn, É., & Wong, S. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.022 · Cited by 2
Inulin might exceed incretin based drugs in the treatment of type 2 diabetes mellitus
Girgiss, M. W., Nicola, W. G., El-Arab, A. M. E., Habib, D. F., Ahmed, N. M., & Youness, E. R. (2019) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/1732 · Cited by 2
Högstedt, A., Iredahl, F., Tesselaar, E., & Farnebo, S. J. (2019) · Microcirculation · doi:10.1111/micc.12597 · Cited by 2
Exploring the activity of the enzyme 11β-hydroxylase in the polycystic ovary syndrome
de Medeiros, S. F., Angelo, L. C. A., de Medeiros, M. A. S., Barbosa, B. B., & Yamamoto, M. M. W. (2020) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2019-0048 · Cited by 2
Gündoğan, K., Doğan, E., Özer, N. T., et al. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1911-165 · Cited by 2
Vitamin D is associated with the hypertriglyceridemic waist phenotype in Brazilian children.
Milagres, L. C., Filgueiras, M. D. S., Rocha, N. P., Juvanhol, L. L., Franceschini, S. C. C., & de Novaes, J. F. (2020) · Journal of public health · doi:10.1093/pubmed/fdaa041 · Cited by 2
Agarwal, R., Virdi, S., Dhooria, S., Sehgal, I. S., & Chaudhry, D. (2022) · The Indian Journal of Chest Diseases and Allied Sciences · doi:10.5005/ijcdas-58-3-177 · Cited by 2
Bahriz, A., Mansour, M., Ibrahim, A., Khalil, D. M., & Elnoury, H. A. (2020) · Benha Medical Journal · doi:10.21608/bmfj.2020.86396 · Cited by 2
Pinto, S. L., Juvanhol, L. L., da Silva, A., Shivappa, N., Hébert, J. R., & Bressan, J. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04756-1 · Cited by 2
Furtado, C. L. M., Iannetta, R., Ferriani, R. A., Silva, A. C. J. D. S. R. E., Martinelli, C. E., Calado, R. T., & dos Reis, R. M. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1770212 · Cited by 2
Nakamura, A., Miyoshi, H., Ukawa, S., Nakamura, K., Nakagawa, T., Terauchi, Y., Tamakoshi, A., & Atsumi, T. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13323 · Cited by 3
Salama, M. M., Kabiel, W. A. Y., Hana, S. S., & Mohamed, G. A. (2020) · Egyptian Liver Journal · doi:10.1186/s43066-020-00039-7 · Cited by 2
Nonoyama, Y., Yamamoto, M., Oba, S., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13398 · Cited by 2
Pragya, P., Yadav, R. K., Khadgawat, D. R., et al. (2020) · Journal of Dietary Supplements · doi:10.1080/19390211.2020.1827116 · Cited by 2
Elebrashy, I., Shaker, O. G., Abdelgalil, S. I., & Yousief, E. M. (2019) · The Egyptian Journal of Internal Medicine · doi:10.4103/ejim.ejim_100_19 · Cited by 2
Gotfredsen, J. L., Hoppe, C., Andersen, R., Andersen, E. W., Landberg, R., Overvad, K., & Tetens, I. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520005164 · Cited by 4
González‐Gil, E. M., Huybrechts, I., Aguilera, C. M., Béghin, L., Breidenassel, C., Gesteiro, E., González‐Gross, M., Henauw, S. D., Kersting, M., Donne, C. L., et al. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa389 · Cited by 3
Wang, J., Lee, I., Lee, W., Lin, S., Lee, W.-L., Liang, K., & Sheu, W. H. (2021) · Journal of Investigative Medicine · doi:10.1136/jim-2020-001646 · Cited by 2
Ausweg aus der Versorgungslücke: voll krankenkassenfinanzierte konservative Adipositastherapie
Frenzel, S. V., Bach, S., Ahrens, S., Hellbardt, M., Hilbert, A., Stümvoll, M., Faßhauer, M., & Schlögl, H. (2021) · Aktuelle Ernährungsmedizin · doi:10.1055/a-1293-3555 · Cited by 2
Shin, C. Y., Lee, H. Y., Kim, G. H., Park, S. Y., Choi, W. S., & Sohn, U. D. (2021) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2021.003 · Cited by 2
Serum visfatin level in prediabetics and its relation to left ventricular function
Abdel-Hassib, M., Hassabo, A. A., Elashmawy, H., & Mansour, M. I. S. (2019) · The Egyptian Journal of Internal Medicine · doi:10.4103/ejim.ejim_119_19 · Cited by 2
El-Masry, S. A., Mahmoud, R., Ahmed, H. H., Al-Tohamy, M., Latif, H. M. A., & Afify, M. A. S. (2021) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2020-0260 · Cited by 2
Swanson, T. N., Parker, M. N., Byrne, M. E., Ramirez, E., Kwarteng, E. A., Faulkner, L. M., Djan, K. G., Zenno, A., Chivukula, K. K., LeMay‐Russell, S., et al. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13286 · Cited by 3
Kazantseva, C. V., Nagornev, S. N., Frolkov, V. K., et al. (2021) · Russian Journal of Physiotherapy Balneology and Rehabilitation · doi:10.17816/1681-3456-2021-20-2-6 · Cited by 2
Călinoiu, L. F., Fărcaș, A. C., Socaci, S., & Vodnar, D. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816450-1.00008-8 · Cited by 2
Physical fitness and activity, metabolic profile, adipokines and endothelial function in children
da Penha, J. T., Gazolla, F. M., Carvalho, C. N. D. M., et al. (2019) · Jornal de Pediatria (Versão em Português) · doi:10.1016/j.jpedp.2018.06.014 · Cited by 2
The Role of Diabetes Mellitus in the Malignant Pancreatic Cyst Neoplasm Diagnosis and Prognosis
Deng, J., Guo, Y., Gu, J., Du, J., Kong, L., Tao, B., Li, J., & Fu, D. (2022) · Cancer Management and Research · doi:10.2147/cmar.s355365 · Cited by 2
Acanthosis Nigricans Is a Strong Predictor of Low Blood Calcidiol Levels in Children and Adolescents
Isart, F. A., Isart-Infante, F. J., Heidel, E., & Sisley, S. R. (2022) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2022.0005 · Cited by 2
BARRETO, B. F. D. M., Punaro, G., ELIAS, M. C., & Parise, E. R. (2022) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.202203000-72 · Cited by 2
Insulin Resistance and Diabetes in Chronic Renal Disease
Simonson, D. C. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-373870-7.00025-9 · Cited by 2
Preterm birth and risk factors for chronic disease : Helsinki Study of Very Low Birth Weight Adults
Hovi, P. (2011) · Työväentutkimus Vuosikirja · Cited by 2
Querales, M., Rojas, S., Quevedo, G., et al. (2014) · Actualidad Contable FACES · Cited by 2
Biomarkers and Risk Factors of Dementia
Schrijvers, E. M. C. (2011) · RePub (Erasmus University Rotterdam) · Cited by 2
Insulin Resistance and the Metabolic Syndrome
Brand-Miller, J. C., & Colagiuri, S. (2012) · Wiley eBooks · doi:10.1002/9781119946045.ch47 · Cited by 2
La condición física como determinante de salud en personas jóvenes
Ruiz, J. R. (2008) · Institutional Repository of the University of Granada (University of Granada) · Cited by 2
Campos, G., Diez‐Ewald, M., Ryder, E., et al. (2008) · PubMed · Cited by 2
Congenital Adrenal Hyperplasia in Adults
Falhammar, H. (2010) · Figshare · Cited by 2
Cafestol: a multi-faced compound kinetics and metabolic effects of cafestol in mice
van Cruchten, S. T. J. (2010) · doi:10.18174/135163 · Cited by 2
Derosa, G., Cicero, A. F. G., Carbone, A., Querci, F., Fogari, E., D’Angelo, A., & Maffioli, P. (2015) · Inflammation · doi:10.1007/s10753-015-0223-0 · Cited by 2
RetractedThe role of dairy products and constituents in metabolic risk management
van Meijl, L. E. C. (2010) · Research Publications (Maastricht University) · doi:10.26481/dis.20101217lm · Cited by 2
Spina, L. D. C., Soares, D. V., Conceição, F. L., et al. (2002) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302002000500007 · Cited by 2
Ishizaka, N., Ishizaka, Y., Toda, E.-I., et al. (2007) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.14.72 · Cited by 2
Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo
Dullaart, R. P. F., Dallinga‐Thie, G. M., & van Tol, A. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02866.x · Cited by 2
Leptin Is Associated with Insulin Resistance in Japanese Migrants
de Almeida-Pititto, B., Gimeno, S. G. A., Sañudo, A., Ribeiro‐Filho, F. F., Ferreira, S. R. G., & Japanese-Brazilian Diabetes Study Group (2005) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2005.3.140 · Cited by 2
Exogenous leptin improves insulin sensitivity in ethanol fed insulin resistant mice
Vairappan, B., & Nalini, N. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.12.003 · Cited by 2
The effect of obesity on venous impedance and outflow measured by ultrasound
Wall, M. L. (2011) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 2
Taniguchi, A., Fukushima, M., Nakai, Y., Kuroe, A., Ohya, M., Ohgushi, M., & Seino, Y. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.060 · Cited by 2
Sjögren, P., Fredrikson, G. N., Rosell, M., et al. (2008) · Metabolism · doi:10.1016/j.metabol.2007.10.011 · Cited by 2
Taşkapan, M. Ç., Keskin, L., Şahin, İ., et al. (2007) · Renal Failure · doi:10.1080/08860220701392355 · Cited by 2
Bestimmung von Insulinresistenz und Insulinsensitivität bei Kindern und Jugendlichen
Heinze, E., Horn, T., Wabitsch, M., Wudy, S. A., Sorgo, W., & Homoki, J. (2002) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-002-0421-3 · Cited by 2
García, J. D. M., Sabio, J. M., Fernández-Torres, C., et al. (2004) · Medicina Clínica · doi:10.1016/s0025-7753(04)74496-6 · Cited by 2
Is insulin an independent predictor of mortality in hemodialysis patients?
Rašić-Milutinović, Z., Peruničić, G., Plješa, S., et al. (2004) · Jugoslovenska medicinska biohemija · doi:10.2298/jmh0401043r · Cited by 2
Choi, H., Park, J., Cho, B. L., et al. (2011) · International braz j urol · doi:10.1590/s1677-55382011000300030 · Cited by 2
Mori, Y., Ishii, H., Hikita, M., & Tajima, N. (2003) · Advances in Therapy · doi:10.1007/bf02849802 · Cited by 2
Kim, S. K., Kim, J. H., Park, J. Y., No, H. S., Jang, K., Heo, J. S., Choi, S. H., Choi, D. W., & Kim, K. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.04.020 · Cited by 2
Middle age is not associated with altered fibrinogen concentration and production in males
Tessari, P., Millioni, R., Vettore, M., Cecchet, D., & Puricelli, L. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0144-1 · Cited by 2
Non-Alcoholic Fatty Liver Disease : A clinical and histopathological study
Ekstedt, M. (2008) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 2
Schindhelm, R. K. (2007) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) · Cited by 2
Larsson, C. (2011) · Lund University Publications (Lund University) · Cited by 2
The GH/IGF-1 system during surgery and catabolism : Focus on metabolism and heart function
Wallin, M. K. E. B. (2007) · Figshare · Cited by 2
Curi, D. D. G. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2007.tde-04102007-121316 · Cited by 2
Jamaludin, U. K. (2013) · UMP Institutional Repository (Universiti Malaysia Pahang) · doi:10.26021/3488 · Cited by 2
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
